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Rehabilitation after nervous system injury, such as spinal cord injury or stroke, can 
improve outcomes when undertaken in the acute or chronic phase (Ward 2017) but it rarely 
restores all lost function in humans. Rehabilitation can be exhausting and the dose of 
rehabilitation available to each patient is also limited by its expense: adjunct therapies that 
enhance rehabilitation would thus be of great value. Animal studies indicate too that the 
effectiveness of rehabilitation declines with time since spinal cord injury. In this issue of Brain, a 
team led by Karim Fouad reports, perhaps surprisingly and counterintuitively, that treatment with 
bacterial endotoxins (lipopolysaccharides; LPS) can enhance medium or high intensity 
rehabilitation in rats with spinal cord injuries that occurred two months previously (Torres-Espín 
et al. 2018).  
This study is an extension of work dating back many decades that indicates that bacterial 
endotoxins (by themselves or in combination with other treatments) can improve anatomical and 
functional recovery after acute spinal cord injury [reviewed in (Popovich et al. 2012)]. In the 
present study, adult rats received mid-cervical (C4) unilateral dorsolateral quadrant spinal cord 
injuries that persistently impaired their ability to grasp and retrieve sugar pellets with their 
previously-preferred paw. Eight and 11 weeks later, rats received intraperitoneal injection of saline 
or lipopolysaccharides at doses that induced effects within the cervical spinal cord (e.g., microglial 
activation) but that induced only mild sickness for less than two days (body temperature was 
typically increased only ~1°C). From eight weeks, rats received either low, medium or higher 
doses of rehabilitation of pellet retrieval for an additional seven or eight weeks.  
The key message of the paper is that medium or high (but not low) doses of rehabilitation 
led to greater success in pellet retrieval in rats treated with LPS than with saline. In animals treated 
with LPS and high doses of rehabilitation, wrist movements during retrieval (“supination”) were 
more normal; anterograde tract tracing showed increased sprouting of the injured corticospinal 
tract in the cervical segment rostral to the injury; and microstimulation of motor cortex evoked 
greater output to the contralateral (disabled) posterior forelimb muscles.  
So how do lipopolysaccharides enhance rehabilitation in rats after spinal cord injury? This 
is a complex question that will take many years to address adequately as we do not yet know how 
even an intact system reaches and grasps. But given the animal data showing that that 
rehabilitation as a monotherapy is more efficient after acute spinal cord injury than after chronic 
injury, then perhaps, when given after chronic injury, LPS enhances rehabilitation by 
recapitulating some of the inflammatory components of the acutely injured state. Acutely, spinal 
cord injury generates Damage Associated Molecular Pattern molecules (DAMPs) and opens the 
blood-brain barrier, facilitating the influx of inflammatory peripheral cells into the injury site. Both 
beneficial and harmful effects have been attributed to the presence and activation of microglia, 
macrophages and lymphocytes. At the injury site, activated immune cells contribute to the 
production of cytokines, proteolytic enzymes and matrix metalloproteinases inducing a reactive 
process of secondary cell death, leading to increased cavitation and cyst formation, and 
exacerbating neurological dysfunction. Paradoxically, inflammation can also be beneficial. The 
effects of macrophages at the injury site depend on the balance of macrophage subtypes (often 
dichotomised as M1 or M2 but shown by transcriptomics to be spectral). “Classically activated 
(M1)” macrophages are pro-inflammatory and contribute to glial scar formation and production of 
pro-inflammatory cytokines, reactive oxygen species, nitric oxide and proteolytic enzymes that 
lead to extracellular matrix degradation and tissue damage. “Alternatively activated (M2)” 
macrophages are anti-inflammatory, provide neural and axonal trophic support, partially degrade 
the glial scar and induce inflammation resolution, thus contributing to wound healing and tissue 
re-modelling. Despite M2 macrophage activities, the resolution of inflammation after spinal cord 
injury is incomplete and the presence of pro-inflammatory macrophages is maintained for long 
periods [reviewed by (Gensel and Zhang 2015)].  
To enhance rehabilitation, what are the key receptors to which LPS must bind and where 
are they? This is not yet known, but others have shown that LPS binds to a co-receptor complex  
– including CD14, LPS-binding protein and TLR4 – on microglia/macrophages, activating them 
via TLR4 for pathogen clearance and boosting the innate immune response. LPS-activated 
macrophages acquire a pro-inflammatory phenotype (M1) and secrete oxygen free radicals, IL-1, 
IL-6, IL-12, TNF-alpha, inducible nitric oxide synthase and chemoattractants that recruit additional 
leucocytes, possibly creating a neurotoxic environment. But the presence of a pro-inflammatory 
mediator at the site of injury is not sufficient reason to assume that it will have detrimental effects, 
and evaluation in experimental animals is necessary to determine whether this is in fact the case. 
The experimental conditions, such as time and dose of LPS injections, as well as the injury model 
seem to be crucial in determining whether the overall effect will be neurotoxic, neuroprotective or 
neuroreparative.  
 Other authors have also reported beneficial effects of single or multiple intraperitoneal 
injections of low doses of LPS and other similar inflammatory agents when applied in the acute 
phase after a lesion. Guth and colleagues observed reduced cavitation and ingrowth of a greater 
number of axons, frequently gathered into fascicles, after spinal cord injury and LPS treatment in 
rats (Guth et al. 1994). Vallières and collaborators observed accelerated myelin clearance from 
white matter tracts undergoing Wallerian degeneration after spinal dorsal hemisection following 
daily systemic injections of LPS; the injections recruited activated macrophages to the injury site, 
although this was not sufficient to promote regeneration of injured sensory axons (Vallieres et al. 
2006). Fouad’s work goes beyond this by showing that LPS can enhance recovery after chronic 
spinal cord injury when combined with medium or high intensity rehabilitation. 
How did LPS and high intensity rehabilitation enhance corticospinal tract sprouting, neural 
output to affected forelimb muscles and functional recovery? In this study, fluorescently-labelled 
LPS was detected in macrophages in the liver and at the site of injury, but not in the spinal cord 
one segment rostral to the injury site and not in cortex. If LPS activates microglia/macrophages 
at the injury site, might some of the mediators liberated by these cells (e.g., Brain-Derived 
Neurotrophic Factor) cause sprouting of corticospinal axons? Perhaps LPS-induced inflammation 
stimulated sprouting of axons and then rehabilitation was important for axonal pathfinding and for 
strengthening of functionally useful connections. This refinement may happen only to circuits 
related to the rehabilitated task, as Torres-Espín et al. found no improvement in other tasks. In 
the future, trans-synaptic tracing and chemogenetic silencing strategies could be used to identify 
the pathways that confer improved hand and arm movements after LPS and rehabilitation. Others 
have shown that application of LPS to motor cortex does not induce regeneration of corticospinal 
axons through or distal to a C3/4 lesion site (Hossain-Ibrahim et al. 2006). If LPS did not induce 
regeneration of corticospinal axons around or through the injury site in Torres-Espín’s work, then 
one possibility is that corticospinal sprouts rostral to the injury formed synapses on short 
propriospinal neurons in upper cervical (C3-C4) segments that project to lower (C6-T1) segments 
in the white matter spared ventral to the C4 dorsolateral injury (Bareyre et al. 2004) (Figures 1A 
and B). Another possibility is that the non-lesioned corticospinal tract sprouted collaterals across 
the midline below the level of the spinal cord injury to form synapses on premotor interneurons 
(Figures 1C and D) as the spared corticospinal tract is known to sprout in response to various 
potential therapies for unilateral spinal cord injury, including LPS plus neurotrophin-3 (Chen et al. 
2008). In a series of papers, David Shine’s group cut one corticospinal tract in the brainstem of 
rats and then overexpressed neurotrophin-3 in lumbar motor neurons on the more-disabled side. 
Neurotrophin-3 induced sprouting of uninjured corticospinal axons across the midline but only 
when applied within two weeks of injury and not when applied four months after injury (Chen et 
al. 2006) unless LPS was injected intraperitoneally (Chen et al. 2008). The parallel between 
Shine’s work and Fouad’s work is that LPS synergised with other therapies (neurotrophin-3 or 
rehabilitation, respectively) in the chronic phase after injury (Chen et al. 2006; Chen et al. 2008).  
To achieve high levels of neurotrophin-3 expression in motor neurons, Shine’s group 
applied an adenoviral vector encoding human preproNeurotrophin-3 to the sciatic nerve on the 
more-disabled side, having cut the nerve to ensure efficient uptake of the vector. It is interesting 
that this proinflammatory stimulus (the delivery of a non-self transgene using an immunogenic 
vector combined with a proinflammatory nerve injury) was insufficient by itself to promote 
corticospinal tract sprouting in their chronic paradigm, which indicates that there is something 
rather special about the stimulus delivered by LPS.  
Could LPS be used to enhance neurorehabilitation in people? People with spinal cord 
injury are often immunocompromised and elevated temperature can exacerbate cell death so 
exposure of vulnerable subjects to a proinflammatory pyrogen might be ruled out for the acute 
phase. In the past, more than 100 people with acute or chronic spinal cord injury or disease have 
been dosed with preparations of bacterial polysaccharides although these case histories were 
only superficially documented (Friedlander and Bailey 1953). To our knowledge there have been 
no clinical trials of LPS for spinal cord injury, although clinical trials of LPS have been run for other 
conditions. A fuller understanding of the mechanisms by which LPS induces benefit might enable 
a targeted approach that can generate Intellectual Property that could enable expensive clinical 
trials: engineered antibodies or small molecules might be developed against the key receptor/cell 
type. 
In closing, it is worth emphasising that evidence continues to accumulate that intensive 
rehabilitation by itself improves outcome even in people with chronic neurological injuries (Ward 
2017). More therefore needs to be done by health care systems to make intensive rehabilitation 
more widely available to those who need and want more. In the longer term, adjunct drug or 




● LPS: Lipopolysaccharides are endotoxins that comprise a large part of the outer membrane 
of gram negative bacteria (e.g., the studies by Fouad and Shine used E. Coli serotype O55:B5, 
>500,000 Endotoxin Units/mg) 
● NT-3: Neurotrophin-3 is a growth factor made abundantly in various tissues (e.g., muscle) 
during infant development and which is necessary for the wiring-up of some neural circuits 
involved in movement. 
● CD14: Cluster of differentiation 14 is a co-receptor that binds to LPS in the presence of 
Lipopolysaccharide Binding Protein. It exists as both a soluble plasma protein and a GPi-
linked protein. 
● TLR-4: Toll-Like Receptor 4 is a transmembrane pattern recognition co-receptor for LPS (and 
HSP-60) that leads to phagocyte activation, stimulating the production of cytokines and 
microbicidal substances by these cells. 
 
Figure Legend 
Figure 1: Lipopolysaccharides and high intensity rehabilitation may induce new circuit 
formation. (A, B) Torres-Espín et al., 2018 show in rats that high intensity rehabilitation of 
grasping initiated eight weeks after dorsolateral cervical spinal cord injury is more effective when 
combined with intraperitoneal injection of lipopolysaccharides. Enhanced sprouting of the affected 
corticospinal tract rostral to the injury (red sprouts in panel A) was accompanied by increased 
output to affected forelimb muscles perhaps via spared short propriospinal neurons (green neuron 
in A and B), the axons of which travel in white matter ventral to the injury site. (C, D) Future 
research may show whether other pathways are also involved. For example, the spared 
corticospinal tract from the other hemisphere (blue pathway in C and D) may sprout axons across 
the spinal midline (green sprouts in D) to form synapses on premotor interneurons involved in 
grasping. This kind of neuroplasticity has been shown before in the lumbar spinal cord when rats 
are treated intraperitoneally with lipopolysaccharides and intraneural injection on the more-
disabled side of an adenoviral vector encoding neurotrophin-3, four months after unilateral 
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Figure 1: Lipopolysaccharides and high intensity rehabilitation may induce new circuit formation. (A, B) Torres-Espín et al., 2018 show in rats that
high intensity rehabilitation of grasping initiated eight weeks after dorsolateral cervical spinal cord injury is more effective when combined with
intraperitoneal injection of lipopolysaccharides. Enhanced sprouting of the affected corticospinal tract rostral to the injury (red sprouts in panel
A) was accompanied by increased output to affected forelimb muscles perhaps via spared short propriospinal neurons (green neuron in A and B)
whose axons travel in white matter ventral to the injury site. (C, D) Future research may show whether other pathways are also involved. For
example, the spared corticospinal tract from the other hemisphere (blue pathway in C and D) may sprout axons across the spinal midline (green
sprouts in D) to form synapses on premotor interneurons involved in grasping. This kind of neuroplasticity has been shown before in the lumbar
spinal cord when rats are treated intraperitoneally with lipopolysaccharides and intraneural injection on the more-disabled side of an adenoviral
vector encoding Neurotrophin-3 four months after unilateral corticospinal tract axotomy in the brainstem (Chen et al 2008).
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